Asker Healthcare Group expands Baltic footprint through full ownership of Ambercell Solutions

Swedish medtech group Asker Healthcare Group has agreed to acquire 100 percent of Baltic medical provider Ambercell Solutions UAB. Subject to regulatory approval, the deal strengthens Asker's presence in Interventional medicine and specialized supply chain services across Lithuania, Latvia, and Estonia.

Swedish medical products and solutions provider Asker Healthcare Group has entered into an agreement to acquire 100 percent of the shares in Lithuania-headquartered Ambercell Solutions UAB. The transaction, which remains subject to customary regulatory approvals, is slated for completion in the fourth quarter of 2026 and is expected to enhance the acquiring group's EBITA margin.

Ambercell Solutions specializes in providing procedure-specific medical packs, consumables, and interventional medicine technologies across Lithuania, Latvia, and Estonia via a proprietary integrated supply chain platform. Employing 45 staff members, the business generated revenue of approximately SEK 250 million over the past twelve months. Asker Healthcare Group operates across 19 European countries with over 5,000 employees, generating revenue of SEK 18 billion by acquiring and scaling local healthcare providers.

This strategic move underscores growing consolidation within Northern Europe's medtech distribution sector. Integrating specialized supply chain management platforms with hospital workflows enables medical staff to optimize procurement, reduce administrative overhead, and mitigate supply chain vulnerabilities in regional healthcare systems.

For market participants and institutional investors, the transaction illustrates ongoing M&A momentum in European healthcare supply chains. Asker's expansion into the Baltic region establishes a stronger commercial foothold in fast-growing European healthcare markets while bolstering overall operational efficiencies across its broader portfolio.